Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

NCT02468193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing's Syndrome
Ectopic Corticotropin Syndrome
Adrenal Adenoma
Adrenal Carcinoma
AIMAH
PPNAD

Interventions

DRUG: Osilodrostat

Sponsor

Novartis Pharmaceuticals